These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
676 related items for PubMed ID: 16761228
1. [Efficacy of tiotropium bromide (Spiriva) in patients with chronic-obstructive pulmonary disease (COPD) of different severities]. Beeh KM, Beier J, Buhl R, Stark-Lorenzen P, Gerken F, Metzdorf N, ATEM-Studiengruppe. Pneumologie; 2006 Jun; 60(6):341-6. PubMed ID: 16761228 [Abstract] [Full Text] [Related]
2. Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). Dutch Study Group. Maesen FP, Smeets JJ, Sledsens TJ, Wald FD, Cornelissen PJ. Eur Respir J; 1995 Sep; 8(9):1506-13. PubMed ID: 8575576 [Abstract] [Full Text] [Related]
3. A randomized study of tiotropium Respimat Soft Mist inhaler vs. ipratropium pMDI in COPD. Voshaar T, Lapidus R, Maleki-Yazdi R, Timmer W, Rubin E, Lowe L, Bateman E. Respir Med; 2008 Jan; 102(1):32-41. PubMed ID: 17996436 [Abstract] [Full Text] [Related]
4. Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD. Keam SJ, Keating GM. Treat Respir Med; 2004 Jan; 3(4):247-68. PubMed ID: 15350163 [Abstract] [Full Text] [Related]
11. Tiotropium bromide: a new long-acting bronchodilator for the treatment of chronic obstructive pulmonary disease. Koumis T, Samuel S. Clin Ther; 2005 Apr; 27(4):377-92. PubMed ID: 15922812 [Abstract] [Full Text] [Related]
13. The efficacy of tiotropium administered via Respimat Soft Mist Inhaler or HandiHaler in COPD patients. van Noord JA, Cornelissen PJ, Aumann JL, Platz J, Mueller A, Fogarty C. Respir Med; 2009 Jan; 103(1):22-9. PubMed ID: 19022642 [Abstract] [Full Text] [Related]
15. Superiority of "triple" therapy with salmeterol/fluticasone propionate and tiotropium bromide versus individual components in moderate to severe COPD. Singh D, Brooks J, Hagan G, Cahn A, O'Connor BJ. Thorax; 2008 Jul; 63(7):592-8. PubMed ID: 18245142 [Abstract] [Full Text] [Related]
16. Short-term effects of inhalative tiotropium/formoterol/budenoside versus tiotropium/formoterol in patients with newly diagnosed chronic obstructive pulmonary disease requiring surgery for lung cancer: a prospective randomized trial. Bölükbas S, Eberlein M, Eckhoff J, Schirren J. Eur J Cardiothorac Surg; 2011 Jun; 39(6):995-1000. PubMed ID: 20970351 [Abstract] [Full Text] [Related]
17. Tiotropium in COPD patients not previously receiving maintenance respiratory medications. Adams SG, Anzueto A, Briggs DD, Menjoge SS, Kesten S. Respir Med; 2006 Sep; 100(9):1495-503. PubMed ID: 16698259 [Abstract] [Full Text] [Related]
18. [A randomized, double-blind, placebo-control study of once-daily inhaled tiotropium in chronic obstructive pulmonary disease]. Yin KS, Zhang DP, Shi Y, Sun LH, Min R, Xiao YL, Xia XR, Tan Y, Fu WZ. Zhonghua Jie He He Hu Xi Za Zhi; 2010 Jul; 33(7):519-23. PubMed ID: 20979799 [Abstract] [Full Text] [Related]